Theriva Biologics Inc.
13F holders, Q3 2024 (September 30)1holders −21
0new positions
21sold out
$0.15avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Theriva Biologics Inc. in their 13F filings, down 21 from Q2 2024. 0 opened new positions and 21 sold out. The largest holder was IFP Advisors, Inc ($43).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U409
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 21 | $283K |
All 13F filers, Q2 2024 → Q3 2024: 1,196,681 shares sold, net −1,196,681 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 296 | $43 |
"% of holder's portfolio" is THERIVA BIOLOGICS INC's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.